News from Clinuvel that Scenesse (their implant of afamelanotide 16mg) has shown a provable positive effect on EPP sufferers in a US Phase 2 Trial. EPP is an acute intolerance to exposure to sunlight and UV. Sufferers of …
scenesse articles ↓
Scenesse One Step Closer for Erythropoietic Protoporphyria (EPP)
November 4th, 2011, by David Pascoe | scenesse
Melanin also Protects You from Radiation !
August 31st, 2011, by David Pascoe | scenesse
Startling news today from the Clinuvel Blog: Melanin also has the ability to protect from radioactive emissions like X-rays and Gamma-rays. How interesting that the chemical that …
Scenesse effective for Solar Urticaria
October 30th, 2010, by David Pascoe | scenesse
For those following the progress of the development of Scenesse (formerly Afamelanotide), some good results from Phase II trials in treating Solar Urticaria. Solar Urticaria is a rare skin condition that can be thought of as being like hives caused my exposure to the sun. Participants received a 16mg implant of Scenesse and were found to have both a significant …
Afamelanotide (Scenesse) now available in Italy
May 17th, 2010, by David Pascoe | melanotan, new treatments, scenesse
Clinuvel has announced today that Italy has pre-empted the approval of Afamelanotide by the FDA in the US by approving it for the treatment of erythropoietic protoporphyria (EPP).
Despite the relatively small number of participants in the Italian trial to treat EPP, and the small number of EPP sufferers …
